Oprozomib
Oprozomib (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome β5（IC50=36 nM）/LMP7（IC50=82 nM）, is orally bioavailable. Oprozomib also has potential antineoplastic activity.
| Catalog Number | T6041 |
| Alternative Name(s) | PR-047 , ONX 0912 |
| Research Area | Autophagy|||Proteases/Proteasome|||Ubiquitination |
| Molecular Formula | C25H32N4O7S |
| CAS# | 935888-69-0 |
| Purity | 99.05% |
| SMILES | s1c(ncc1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)[C@@]1(OC1)C)Cc1ccccc1)COC)COC)C |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Oprozomib |
| Additional Information | https://www.targetmol.com/datasheet/T6041 |